Vaccination with a Mixed Vaccine of Autogenous and Allogeneic Breast Cancer Cells and Tumor Associated Antigens CA15-3, CEA and CA125 - Results in Immune and Clinical Responses in Breast Cancer Patients-Reference-Cited by-同舟云学术

Vaccination with a Mixed Vaccine of Autogenous and Allogeneic Breast Cancer Cells and Tumor Associated Antigens CA15-3, CEA and CA125 - Results in Immune and Clinical Responses in Breast Cancer Patients

Published:2000-10 Issue:5 Volume:15 Page:495-505
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Jiang Xian Peng,Yang Ding C.,Elliott Robert L.,Head Jonathan F.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2000.15.495

Reference33 articles.

1. 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology.

2. c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value

3. Breast cancer immunotherapy: Current status and future prospects

4. A Phase I Trial of a Synthetic Mucin Peptide Vaccine

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Vaccines Designed Based the Nanoparticle and Tumor Cells for the Treatment of Tumors: A Perspective;IET Nanobiotechnology;2024-02-24

2. CEA vaccines;Human Vaccines & Immunotherapeutics;2023-12-13

3. Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells;International Journal of Molecular Sciences;2023-03-08

4. Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches;Journal of Controlled Release;2022-09

5. Immunological Landscape of HER-2 Positive Breast Cancer;Cancers;2022-06-28